Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
-1.44%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$40.3B
AUM Growth
-$3.3B
(-7.6%)
Cap. Flow
-$1.67B
Cap. Flow
% of AUM
-4.14%
Top 10 Holdings %
Top 10 Hldgs %
21.18%
Holding
1,160
New
85
Increased
251
Reduced
431
Closed
113
Top Buys
| 1 |
AVLR
Avalara, Inc.
AVLR
|
+$153M |
| 2 |
EOG Resources
EOG
|
+$127M |
| 3 |
TJX Companies
TJX
|
+$121M |
| 4 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
+$113M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$99.1M |
Top Sells
| 1 |
Royalty Pharma
RPRX
|
+$343M |
| 2 |
Textron
TXT
|
+$175M |
| 3 |
Burlington
BURL
|
+$166M |
| 4 |
Exxon Mobil
XOM
|
+$118M |
| 5 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$111M |
Sector Composition
| 1 | Technology | 23.31% |
| 2 | Healthcare | 17.41% |
| 3 | Financials | 15.7% |
| 4 | Consumer Discretionary | 9.78% |
| 5 | Industrials | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
726
W.R. Berkley
WRB
$27.4B
| $6.98M | 0.02% |
162,225
+97,500
| +151% | +$4.2M |
|
|
INZY
727
DELISTED
Inozyme Pharma
INZY
| $6.96M | 0.02% |
2,596,672
+50,000
| +2% | +$134K |
|
728
Invitation Homes
INVH
$18.4B
| $6.95M | 0.02% |
+205,922
| New | +$6.95M |
|
|
ATAQ
729
DELISTED
Altimar Acquisition Corp. III
ATAQ
| $6.94M | 0.02% |
700,000
| – | – |
|
730
Lincoln National
LNC
$7.88B
| $6.93M | 0.02% |
157,861
-10,500
| -6% | -$461K |
|
|
FSRX
731
DELISTED
FinServ Acquisition Corp. II Class A Common Stock
FSRX
| $6.89M | 0.02% |
700,000
| – | – |
|
732
Brown-Forman Class B
BF.B
$12.9B
| $6.88M | 0.02% |
103,282
+9,950
| +11% | +$662K |
|
733
APi Group
APG
$14.6B
| $6.8M | 0.02% |
768,926
+662,396
| +622% | +$5.86M |
|
734
Qorvo
QRVO
$8.26B
| $6.8M | 0.02% |
85,600
+7,200
| +9% | +$572K |
|
|
AYX
735
DELISTED
Alteryx, Inc.
AYX
| $6.7M | 0.02% |
+120,000
| New | +$6.7M |
|
736
Axsome Therapeutics
AXSM
$6.19B
| $6.69M | 0.02% |
150,000
-633,662
| -81% | -$28.3M |
|
737
W.W. Grainger
GWW
$47.5B
| $6.67M | 0.02% |
13,635
-4,600
| -25% | -$2.25M |
|
738
Sweetgreen
SG
$1.03B
| $6.67M | 0.02% |
+360,500
| New | +$6.67M |
|
739
StepStone Group
STEP
$4.81B
| $6.67M | 0.02% |
272,101
-110,235
| -29% | -$2.7M |
|
740
Wynn Resorts
WYNN
$12.8B
| $6.64M | 0.02% |
105,400
-4,500
| -4% | -$284K |
|
|
EGRX
741
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $6.61M | 0.02% |
250,000
| – | – |
|
742
Sealed Air
SEE
$4.83B
| $6.59M | 0.02% |
147,975
-4,200
| -3% | -$187K |
|
743
Ultragenyx Pharmaceutical
RARE
$3.02B
| $6.42M | 0.02% |
155,062
-524,938
| -77% | -$21.7M |
|
744
A.O. Smith
AOS
$10.2B
| $6.36M | 0.02% |
130,892
-4,500
| -3% | -$219K |
|
745
Invesco
IVZ
$9.88B
| $6.35M | 0.02% |
463,469
+112,800
| +32% | +$1.55M |
|
746
Valaris
VAL
$3.75B
| $6.25M | 0.02% |
+127,769
| New | +$6.25M |
|
747
Franklin Resources
BEN
$12.6B
| $6.23M | 0.02% |
289,400
-2,200
| -0.8% | -$47.3K |
|
|
RETA
748
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $6.03M | 0.02% |
240,024
-784,976
| -77% | -$19.7M |
|
|
HERA
749
DELISTED
FTAC Hera Acquisition Corp. Class A Ordinary Shares
HERA
| $6.02M | 0.01% |
606,700
| – | – |
|
|
CTLT
750
DELISTED
CATALENT, INC.
CTLT
| $5.98M | 0.01% |
82,600
-104,000
| -56% | -$7.53M |
|